Keeping Track: Oncology Filings Galore In Run-Up To ASCO Meeting
The latest cancer drug development news and highlights from our FDA Performance Tracker.
You may also be interested in...
Keeping Track: Another Gene Therapy Approval, Several Priority Review Designations, And Many Resubmissions
The latest drug development news and highlights from our US FDA Performance Tracker.
Cancer supplements took center stage for US FDA this week, but OptiNose Inc.'s corticosteroid Xhance also took a bow.
The latest drug development news and US FDA highlights from our Performance Tracker.